Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy of the addition of prednisolone to conventional initial
treatment (intravenous immunoglobulin [IVIG] plus aspirin) in reducing coronary artery lesion
in children with Kawasaki disease (KD) .
Phase:
Phase 3
Details
Lead Sponsor:
Children's Hospital of Fudan University
Collaborators:
Beijing Children's Hospital Chengdu Women's and Children's Central Hospital Children's Hospital of Chongqing Medical University Children's Hospital Of Soochow University First People's Hospital of Hangzhou Inner Mongolia People's Hospital Jiangxi Province Children's Hospital Qilu Hospital of Shandong University Shengjing Hospital Sichuan Provincial People's Hospital The First Hospital of Jilin University Third Affiliated Hospital of Zhengzhou University Wuhan Union Hospital, China Yuying Children's Hospital of Wenzhou Medical University